Medical Properties Trust, Inc. (NYSE:MPW) Given Consensus Recommendation of “Buy” by Brokerages

Medical Properties Trust, Inc. (NYSE:MPWGet Rating) has been given a consensus recommendation of “Buy” by the eleven analysts that are currently covering the firm, MarketBeat.com reports. Five research analysts have rated the stock with a hold rating, two have given a buy rating and one has given a strong buy rating to the company. The average 12 month price objective among brokers that have issued ratings on the stock in the last year is $24.13.

MPW has been the subject of a number of analyst reports. StockNews.com initiated coverage on Medical Properties Trust in a research report on Thursday, March 31st. They issued a “hold” rating for the company. Bank of America cut Medical Properties Trust from a “buy” rating to a “neutral” rating and set a $21.00 target price for the company. in a report on Friday, March 11th. Credit Suisse Group reduced their price target on Medical Properties Trust from $27.00 to $26.00 and set an “outperform” rating on the stock in a report on Monday, February 14th. Deutsche Bank Aktiengesellschaft cut shares of Medical Properties Trust from a “buy” rating to a “hold” rating and lowered their price target for the company from $27.00 to $25.00 in a research report on Monday, January 3rd. Finally, Truist Financial cut their price objective on shares of Medical Properties Trust from $26.00 to $23.00 and set a “hold” rating for the company in a research report on Thursday, March 24th.

In other news, Director Michael G. Stewart sold 6,000 shares of Medical Properties Trust stock in a transaction on Thursday, March 10th. The stock was sold at an average price of $20.26, for a total value of $121,560.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Edward K. Aldag, Jr. sold 615,000 shares of the stock in a transaction dated Wednesday, March 30th. The stock was sold at an average price of $21.33, for a total value of $13,117,950.00. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 906,000 shares of company stock valued at $19,235,910. 1.04% of the stock is currently owned by insiders.

Hedge funds and other institutional investors have recently bought and sold shares of the company. Dark Forest Capital Management LP acquired a new position in Medical Properties Trust during the 3rd quarter worth $26,000. Moors & Cabot Inc. acquired a new position in shares of Medical Properties Trust during the third quarter worth about $27,000. Mystic Asset Management Inc. purchased a new stake in shares of Medical Properties Trust during the fourth quarter worth approximately $27,000. Sageworth Trust Co of South Dakota acquired a new stake in Medical Properties Trust in the fourth quarter valued at approximately $36,000. Finally, Exane Derivatives lifted its stake in Medical Properties Trust by 542.6% in the fourth quarter. Exane Derivatives now owns 1,748 shares of the real estate investment trust’s stock worth $41,000 after acquiring an additional 1,476 shares during the last quarter. 80.77% of the stock is owned by institutional investors and hedge funds.

Shares of Medical Properties Trust stock traded down $0.50 during trading hours on Monday, reaching $20.60. 114,687 shares of the company’s stock were exchanged, compared to its average volume of 4,790,849. The business has a fifty day moving average of $20.82 and a two-hundred day moving average of $21.45. The company has a market capitalization of $12.28 billion, a P/E ratio of 18.85, a price-to-earnings-growth ratio of 1.72 and a beta of 0.58. The company has a quick ratio of 3.99, a current ratio of 3.99 and a debt-to-equity ratio of 1.34. Medical Properties Trust has a 1 year low of $19.39 and a 1 year high of $24.13.

Medical Properties Trust (NYSE:MPWGet Rating) last posted its quarterly earnings results on Thursday, February 3rd. The real estate investment trust reported $0.34 earnings per share for the quarter, missing analysts’ consensus estimates of $0.46 by ($0.12). The business had revenue of $409.30 million for the quarter, compared to analyst estimates of $403.73 million. Medical Properties Trust had a return on equity of 7.83% and a net margin of 42.47%. The business’s revenue was up 22.6% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.41 earnings per share. As a group, research analysts predict that Medical Properties Trust will post 1.87 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, April 14th. Investors of record on Thursday, March 17th will be issued a $0.29 dividend. This is a positive change from Medical Properties Trust’s previous quarterly dividend of $0.28. This represents a $1.16 annualized dividend and a yield of 5.63%. The ex-dividend date is Wednesday, March 16th. Medical Properties Trust’s payout ratio is 105.45%.

About Medical Properties Trust (Get Rating)

Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospitals with 431 facilities and roughly 43,000 licensed beds in nine countries and across four continents on a pro forma basis.

Read More

Analyst Recommendations for Medical Properties Trust (NYSE:MPW)

Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.